Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dyslipidemia Management in Chinese Post Stroke Patients

NCT01897883 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01897883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01897883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dyslipidemia Management in Chinese Post Stroke Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 31, 2013
Completion date
August 31, 2014
Enrollment
5,000 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

brain ischemia,stoke